Ganglion Impar vs Coccygeal Nerve Radiofrequency Ablation in Chronic Coccydynia
Comparison of Fluoroscopy-Guided Ganglion Impar and Ultrasound-Guided Coccygeal Nerve Radiofrequency Ablation in Patients With Chronic Coccydynia: A Prospective Randomized Study
1 other identifier
interventional
50
1 country
1
Brief Summary
Chronic coccydynia is a condition characterized by persistent pain in the coccyx region that significantly affects daily activities and quality of life. When conservative treatments fail, interventional pain procedures such as radiofrequency ablation may be considered. This single-center, prospective, randomized study compared two radiofrequency ablation techniques used in the treatment of chronic coccydynia: fluoroscopy-guided ganglion impar radiofrequency ablation and ultrasound-guided coccygeal nerve radiofrequency ablation. Adult patients with chronic coccydynia who did not respond to medical treatment were randomly assigned to receive one of these two interventions. Pain intensity and functional disability were evaluated using standardized assessment tools before the procedure and during follow-up visits at 3 weeks and 3 months after treatment. The primary objective was to compare pain relief between the two techniques at 3 months. Secondary objectives included evaluation of functional improvement and procedure-related complications. The results of this study provide comparative information on the effectiveness and safety of these two commonly used radiofrequency techniques and may help guide clinicians in selecting appropriate interventional treatments for patients with chronic coccydynia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedFirst Submitted
Initial submission to the registry
February 16, 2026
CompletedFirst Posted
Study publicly available on registry
February 23, 2026
CompletedFebruary 23, 2026
February 1, 2026
11 months
February 16, 2026
February 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain reduction at 3 months
Pain intensity was assessed using the Numeric Rating Scale (NRS). The primary outcome was defined as the proportion of patients achieving at least a 50% reduction in NRS score at 3 months compared with baseline.
3 months
Secondary Outcomes (3)
Functional improvement at 3 months
3 months
Change in pain intensity over time
Baseline, 3 weeks, and 3 months
Procedure-related complications
Up to 3 months
Study Arms (2)
Ganglion Impar Radiofrequency Ablation
EXPERIMENTALParticipants underwent fluoroscopy-guided ganglion impar thermal radiofrequency ablation.
Coccygeal Nerve Radiofrequency Ablation
EXPERIMENTALThermal radiofrequency ablation of the coccygeal nerve performed under ultrasound guidance using standard interventional pain management techniques.
Interventions
Thermal radiofrequency ablation of the ganglion impar performed under fluoroscopic guidance using standard interventional pain management techniques.
Thermal radiofrequency ablation of the coccygeal nerve performed under ultrasound guidance using standard interventional pain management techniques.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 75 years Diagnosis of chronic coccydynia lasting longer than 3 months Numeric Rating Scale (NRS) score ≥ 4 at baseline Inadequate response to conservative medical treatment Ability to understand the study procedures and provide written informed consent
You may not qualify if:
- Acute coccygeal fracture or recent trauma Local or systemic infection Known malignancy involving the pelvic or sacrococcygeal region Coagulation disorders or ongoing anticoagulant therapy that cannot be safely discontinued Known allergy to local anesthetics or materials used in the procedure Severe psychiatric disorders or cognitive impairment interfering with study participation Pregnancy or breastfeeding
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Of Health Sciences, Gulhane School Of Medicine, Department Of Algology,
Ankara, Etlik, 06010, Turkey (Türkiye)
Related Publications (5)
Genc Perdecioglu GR, Yildiz G. Coccygeal Nerve Blockade vs. Impar Ganglion Blockade in Coccydynia: A Randomised Clinical Trial. Cureus. 2024;16(9):e69118.
BACKGROUNDCan E, Yildiz G, Akkaya OT, et al. Ultrasound-Guided Coccygeal Nerve Radiofrequency Ablation and Steroid Injection: Combination Therapy for Coccydynia. J Ultrasound Med. 2024;43(1):57-64.
BACKGROUNDChoudhary R, et al. Improvement in pain following ganglion impar blocks and radiofrequency ablation in coccygodynia patients: a systematic review. Rev Bras Ortop (Sao Paulo). 2021;56(5):558-566.
BACKGROUNDElkhashab Y, Ng A. A review of current treatment options for coccygodynia. Curr Pain Headache Rep. 2018;22(4):28.
BACKGROUNDPatijn J, Janssen M, Hayek S, Mekhail N, Van Zundert J. Coccygodynia. Pain Pract. 2010;10(6):554-559.
RESULT
Study Officials
- STUDY DIRECTOR
ALP E Çelenlioğlu, MD
Saglik Bilimleri Universitesi
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 16, 2026
First Posted
February 23, 2026
Study Start
November 11, 2024
Primary Completion
September 30, 2025
Study Completion
September 30, 2025
Last Updated
February 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- 3 months after publication
- Access Criteria
- Access to de-identified individual participant data and supporting documents, including the study protocol and statistical analysis plan, will be granted to qualified researchers upon reasonable request. Requests will be reviewed by the study investigators and must include a methodologically sound proposal. Data sharing will be conducted in accordance with institutional policies and applicable data protection regulations.
De-identified individual participant data underlying the results reported in the published article.